These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3148001)

  • 21. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R; Cordido F; Peñalva A; Alvarez CV; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
    Valcavi R; Zini M
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the growth-hormone-releasing hormone test in short normal and growth-hormone-deficient children.
    Cavallo L; Laforgia N; Acquafredda A; Russo R; Zecchino C; Spadaro D; Arrigo T; De Luca F
    Horm Res; 1990; 34(1):13-6. PubMed ID: 2074087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects--a preliminary study.
    Murck H; Frieboes RM; Schier T; Steiger A
    Pharmacopsychiatry; 1997 Jul; 30(4):122-4. PubMed ID: 9271777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency.
    Bozzola M; Tatò L; Cisternino M; Nava C; Valtorta A; Chiesa M; Severi F; Gaburro D
    J Endocrinol Invest; 1986 Dec; 9(6):503-6. PubMed ID: 3106460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.
    Robinson BM; Friberg RD; Bowers CY; Barkan AL
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.
    Cappa M; Loche S; Salvatori R; Faedda A; Borrelli P; Cella SG; Pintor C; Müller EE
    J Endocrinol Invest; 1991 Jan; 14(1):41-5. PubMed ID: 2045624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
    Gelato MC; Rittmaster RS; Pescovitz OH; Nicoletti MC; Nixon WE; D'Agata R; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Aug; 61(2):223-8. PubMed ID: 3924946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.